Free Trial

Encompass Health (EHC) Stock Forecast & Price Target

$85.36
+0.09 (+0.11%)
(As of 07/19/2024 ET)

Encompass Health - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 10 Wall Street analysts who have issued ratings for Encompass Health in the last 12 months, the stock has a consensus rating of "Buy." Out of the 10 analysts, 8 have given a buy rating, and 2 have given a strong buy rating for EHC.

Consensus Price Target

$96.50
13.05% Upside
High Forecast$113.00
Average Forecast$96.50
Low Forecast$80.00

According to the 10 analysts' twelve-month price targets for Encompass Health, the average price target is $96.50. The highest price target for EHC is $113.00, while the lowest price target for EHC is $80.00. The average price target represents a forecasted upside of 13.05% from the current price of $85.36.

TypeCurrent Forecast
7/22/23 to 7/21/24
1 Month Ago
6/22/23 to 6/21/24
3 Months Ago
4/23/23 to 4/22/24
1 Year Ago
7/22/22 to 7/22/23
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
2 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
8 Buy rating(s)
7 Buy rating(s)
7 Buy rating(s)
5 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$96.50$93.29$83.22$71.64
Forecasted Upside13.05% Upside16.19% Upside16.91% Upside20.21% Upside
Get Encompass Health Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for EHC and its competitors with MarketBeat's FREE daily newsletter.

EHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Encompass Health Stock vs. The Competition

TypeEncompass HealthMedical CompaniesS&P 500
Consensus Rating Score
3.20
2.72
2.51
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside13.05% Upside3,283.13% Upside10.06% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/15/2024Truist Financial
1 of 5 stars
 Boost TargetBuy ➝ Buy$95.00 ➝ $100.00+14.97%
7/10/2024Barclays
2 of 5 stars
 Boost TargetOverweight ➝ Overweight$108.00 ➝ $113.00+33.30%
7/10/2024Leerink Partnrs
0 of 5 stars
W. Mayo
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
7/10/2024SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$100.00+19.09%
6/5/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$94.00 ➝ $94.00+10.15%
5/22/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$83.00 ➝ $95.00+11.06%
4/26/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingStrong-Buy ➝ Strong-Buy$85.00 ➝ $95.00+14.89%
4/25/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$93.00 ➝ $95.00+14.85%
2/7/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Haase
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
8/4/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$76.00 ➝ $80.00+13.35%
5/1/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$70.00 ➝ $73.00+12.50%
4/28/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$69.00 ➝ $74.00+16.65%
2/8/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$68.00 ➝ $73.00+24.00%
8/4/2022BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$83.00 ➝ $65.00+23.18%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 10:00 PM ET.

EHC Forecast - Frequently Asked Questions

What is Encompass Health's forecast for 2024?

According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for Encompass Health is $96.50, with a high forecast of $113.00 and a low forecast of $80.00.

Should I buy or sell Encompass Health stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last twelve months. There are currently 8 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" EHC shares.

Does Encompass Health's stock price have much upside?

According to analysts, Encompass Health's stock has a predicted upside of 16.51% based on their 12-month stock forecasts.

Has Encompass Health been upgraded by Wall Street analysts recently?

Over the previous 90 days, Encompass Health's stock had 1 upgrade by analysts.

What analysts cover Encompass Health?

Encompass Health has been rated by research analysts at Barclays, Leerink Partnrs, Mizuho, Raymond James, Royal Bank of Canada, Stephens, SVB Leerink, and Truist Financial in the past 90 days.

Do Wall Street analysts like Encompass Health more than its competitors?

Analysts like Encompass Health more than other "medical" companies. The consensus rating for Encompass Health is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how EHC compares to other companies.


This page (NYSE:EHC) was last updated on 7/21/2024 by MarketBeat.com Staff

From Our Partners